Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel Carracedo

Showing results (331-340 of 376) with videos related to

Pageof 38
Sort By:
Plos Genetics|March 14, 2012
Development of a panel of genome-wide ancestry informative markers to study admixture throughout the AmericasJoshua Mark Galanter, Juan Carlos Fernandez-Lopez, Christopher R Gignoux, et al.
Schizophrenia Bulletin|September 12, 2019
Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI StudyLotta-Katrin Pries, Agustin Lage-Castellanos, Philippe Delespaul, et al.
Frontiers in Psychiatry|October 15, 2019
White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?Elaine Schepers, Richel Lousberg, Sinan Guloksuz, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2019
Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI studySinan Guloksuz, Lotta-Katrin Pries, Philippe Delespaul, et al.
Psychological Medicine|August 16, 2019
Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI studyJim van Os, Lotta-Katrin Pries, Philippe Delespaul, et al.
Redox Biology|July 1, 2022
Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissueAlba Gonzalez-Franquesa, Pau Gama-Perez, Marta Kulis, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 19, 2021
Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI studyGamze Erzin, Lotta-Katrin Pries, Jim van Os, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 2, 2022
The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI studyLaura Fusar-Poli, Lotta-Katrin Pries, Jim van Os, et al.
Plos One|February 17, 2017
Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsClint Mizzi, Eleni Dalabira, Judit Kumuthini, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 18, 2021
Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI studyLaura Fusar-Poli, Lotta-Katrin Pries, Jim van Os, et al.
Pageof 38

Showing results (331-340 of 376) with videos related to

Sort By:
Pageof 38
Plos Genetics|March 14, 2012
Development of a panel of genome-wide ancestry informative markers to study admixture throughout the AmericasJoshua Mark Galanter, Juan Carlos Fernandez-Lopez, Christopher R Gignoux, et al.
Schizophrenia Bulletin|September 12, 2019
Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI StudyLotta-Katrin Pries, Agustin Lage-Castellanos, Philippe Delespaul, et al.
Frontiers in Psychiatry|October 15, 2019
White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?Elaine Schepers, Richel Lousberg, Sinan Guloksuz, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2019
Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI studySinan Guloksuz, Lotta-Katrin Pries, Philippe Delespaul, et al.
Psychological Medicine|August 16, 2019
Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI studyJim van Os, Lotta-Katrin Pries, Philippe Delespaul, et al.
Redox Biology|July 1, 2022
Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissueAlba Gonzalez-Franquesa, Pau Gama-Perez, Marta Kulis, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 19, 2021
Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI studyGamze Erzin, Lotta-Katrin Pries, Jim van Os, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 2, 2022
The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI studyLaura Fusar-Poli, Lotta-Katrin Pries, Jim van Os, et al.
Plos One|February 17, 2017
Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsClint Mizzi, Eleni Dalabira, Judit Kumuthini, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 18, 2021
Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI studyLaura Fusar-Poli, Lotta-Katrin Pries, Jim van Os, et al.
Pageof 38